J&J Covid vaccine recipients are better off getting Pfizer or Moderna booster, NIH study suggests

Health, Fitness & Food

Pfizer-BioNTech Covid-19 vaccines at a senior living facility in Worcester, Pennsylvania, U.S., on Wednesday, Aug. 25, 2021.
Hannah Beier | Bloomberg | Getty Images

Johnson & Johnson Covid-19 vaccine recipients are better off getting a booster shot from Pfizer or Moderna, a highly anticipated U.S. study suggested Wednesday.

The study on “mixing and matching” Covid vaccines included more than 450 adults who have received one of the three regimens currently available in the United States: J&J’s, Moderna’s or Pfizer’s. The study hasn’t yet been peer-reviewed.

Volunteers were divided into groups and received an extra shot of their original vaccine or a booster from a different company.

This is a developing story. Please check back for updates.

Products You May Like

Articles You May Like

Butternut Squash Ravioli with Sage Butter
10 Under Armour Leggings With Pockets That You’ll Want to Wear For Every Workout
Two Meals a Day for Faster Weight Loss
15 Self-Care Products We’re Actually Using Right Now
These Arm Workouts Pack a Serious Punch, and You Can Knock Them Out in 30 Minutes

Leave a Reply

Your email address will not be published. Required fields are marked *